OSHQOZON-ICHAK YARASIDAN QON KETISHIDA SHOSHILINCH TIBBIY YORDAM

Authors

  • Alloberdiyev Asror Abrorovich Respublika tez tibbiy yordam markazi buxoro filiali olot tuman tez yordam stansiyasi vrachi Reanimatolog anesteziolog Author

Keywords:

O’n ikki barmoqli ichak va oshqozon yarasi, qon ketishi, embolizatsiya, jarrohlik, endoskopiya

Abstract

O’tkir oshqozon-ichak yarasidan qon ketishi hali ham kasalxonaga yotqizishning asosiy sababi hisoblanadi. Ayniqsa, o’n ikki barmoqli ichak yarasidan qon ketishini davolashda oshqozon yarasiga nisbatan kasallanish va o’lim darajasi yuqori bo’lganligi sababli tizimli terapevtik yondashuv talab etiladi. Ushbu qon ketadigan yaralar bilan og’rigan bemorlar ko’pincha yuqori xavfli vaziyatda bo’lib, multidissiplinar davolashni talab qiladi. Ushbu maqolada qon ketayotgan o’n ikki barmoqli ichak yarasini zamonaviy davolashga tizimli yondashuvni taqdim etadi va yuqori xavfli vaziyatlarda davolash amaliyotini yoritib beradi. Dastlabki davolash, jumladan farmakologik terapiya, xavf stratifikatsiyasi, endoskopiya, jarrohlik va transkateter arterial embolizatsiya ko’rib chiqiladi va ularning o’n ikki barmoqli ichak yarasidan qon ketishini boshqarishdagi roli tanqidiy muhokama qilinadi. Bundan tashqari, profilaktik terapevtik yondashuvlar bo’yicha kelajakdagi istiqbol ko’rsatilgan.

References

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311-5.

2. Cave DR. Transmission and epidemiology of Helicobacter pylori. Am J Med. 1996 May 20;100(5A):12S-17S; discussion 17S-18S.

3. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995;9 Suppl 2:33-9.

4. Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther. 1996 Apr;10 Suppl 1:29-37.

5. Peskar BM. Role of cyclooxygenase isoforms in gastric mucosal defence. J Physiol Paris. 2001 Jan-Dec;95(1-6):3-9.

6. Lee JY, Kim N. Diagnosis of Helicobacter pylori by invasive test: histology. Ann Transl Med. 2015 Jan;3(1):10.

7. Wilcox CM, Clark WS. Features associated with painless peptic ulcer bleeding. Am J Gastroenterol. 1997 Aug;92(8):1289-92.

8. Chey WD, Wong BC., Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007 Aug;102(8):1808-25.

9. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017 Feb;112(2):212-239.

10. Meran JG, Wagner S, Hotz J, Manns M. [Differential diagnosis of peptic ulcer]. Wien Med Wochenschr. 1992;142(8-9):154-61.

11. Lau JY, Sung JJ, Lam YH, Chan AC, Ng EK, Lee DW, Chan FK, Suen RC, Chung SC. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med. 1999 Mar 11;340(10):751-6. 12. Behrman SW. Management of complicated peptic ulcer disease. Arch Surg. 2005 Feb;140(2):201-8.

Downloads

Published

2025-05-26